San Diego-based Viking Therapeutics marked alone as a significant competitor within the weight loss drug sector in February right after revealing promising info from the mid-phase trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when offered as being a weekly injection and in March the company

Even businesses with candidates currently from the later on phases of screening are still gonna have to have various yrs to gather and system the info and, should items pan out, time to work with regulators to protected acceptance. Launching the drug is another make a difference entirely and shoring up enough provides has established complicated ev